Item | Information |
---|---|
CAS RN | 51-48-9 |
Chemical Name | Thyroxine |
Substance ID | 24A6024 |
Classification year (FY) | FY2012 |
Ministry who conducted the classification | Ministry of Health, Labour and Welfare (MHLW)/Ministry of the Environment (MOE) |
New/Revised | New |
Classification result in other fiscal year | |
Download of Excel format | Excel file |
Item | Information |
---|---|
Guidance used for the classification (External link) | Physical Hazards and Health Hazards: GHS Classification Guidance by the Japanese Government (July, 2010) Environmental Hazards: UN GHS Document (4th revised edition) |
UN GHS document (External link) | UN GHS document |
Definitions/Abbreviations (Excel file) | Definitions/Abbreviations |
Model Label by MHLW (External link) | MHLW Website (in Japanese Only) |
Model SDS by MHLW (External link) | MHLW Website (in Japanese Only) |
OECD/eChemPortal (External link) | eChemPortal |
Hazard class | Classification |
Pictogram Signal word |
Hazard statement (code) |
Precautionary statement (code) |
Rationale for the classification | |
---|---|---|---|---|---|---|
1 | Explosives | Not applicable |
- |
- | - | There are no chemical groups associated with explosive properties present in the molecule. |
2 | Flammable gases (including chemically unstable gases) | Not applicable |
- |
- | - | Solid (GHS definition) |
3 | Aerosols | Not applicable |
- |
- | - | Not aerosol products. |
4 | Oxidizing gases | Not applicable |
- |
- | - | Solid (GHS definition) |
5 | Gases under pressure | Not applicable |
- |
- | - | Solid (GHS definition) |
6 | Flammable liquids | Not applicable |
- |
- | - | Solid (GHS definition) |
7 | Flammable solids | Classification not possible |
- |
- | - | No data available. |
8 | Self-reactive substances and mixtures | Not applicable |
- |
- | - | There are no chemical groups present in the molecule associated with explosive or self-reactive properties. |
9 | Pyrophoric liquids | Not applicable |
- |
- | - | Solid (GHS definition) |
10 | Pyrophoric solids | Classification not possible |
- |
- | - | No data available. |
11 | Self-heating substances and mixtures | Classification not possible |
- |
- | - | No data available. |
12 | Substances and mixtures which, in contact with water, emit flammable gases | Not applicable |
- |
- | - | The chemical structure of the substance does not contain metals or metalloids (B, Si, P, Ge, As, Se, Sn, Sb, Te, Bi, Po, At). |
13 | Oxidizing liquids | Not applicable |
- |
- | - | Solid (GHS definition) |
14 | Oxidizing solids | Not applicable |
- |
- | - | The substance is an organic compound containing oxygen (but not fluorine or chlorine) which is chemically bonded only to carbon or hydrogen. |
15 | Organic peroxides | Not applicable |
- |
- | - | Organic compounds containing no bivalent -O-O- structure. |
16 | Corrosive to metals | Classification not possible |
- |
- | - | Test methods applicable to solid substances are not available. |
Hazard class | Classification |
Pictogram Signal word |
Hazard statement (code) |
Precautionary statement (code) |
Rationale for the classification | |
---|---|---|---|---|---|---|
1 | Acute toxicity (Oral) | Classification not possible |
- |
- | - | No data available. |
1 | Acute toxicity (Dermal) | Classification not possible |
- |
- | - | No data available. |
1 | Acute toxicity (Inhalation: Gases) | Not applicable |
- |
- | - | Solid (GHS definition) |
1 | Acute toxicity (Inhalation: Vapours) | Classification not possible |
- |
- | - | No data available. |
1 | Acute toxicity (Inhalation: Dusts and mists) | Classification not possible |
- |
- | - | No data available. |
2 | Skin corrosion/irritation | Classification not possible |
- |
- | - | No data available. |
3 | Serious eye damage/eye irritation | Classification not possible |
- |
- | - | No data available. |
4 | Respiratory sensitization | Classification not possible |
- |
- | - | No data available. |
4 | Skin sensitization | Classification not possible |
- |
- | - | No data available. |
5 | Germ cell mutagenicity | Classification not possible |
- |
- | - | No data available. |
6 | Carcinogenicity | Classification not possible |
- |
- | - | No data available. |
7 | Reproductive toxicity | Category 2 |
![]() Warning |
H361 |
P308+P313
P201 P202 P280 P405 P501 |
It is reported that oral administration to rats on gestational days 0-20 caused cataract in 38% of the offspring (HSDB (2003), Teratogenic (12th, 2007), corresponding to List 2). And as for humans, eye defects were observed in an infant after treatment by this substance on the mother during gestation, and medication with this substance was considered to be a risk factor for limb defects among 108 cases analyzed. Furthermore, possible associations were found with cardiovascular anomalies, Down syndrome, and polydactyly, which were seen in 537 mother-child pairs exposed during the first trimester (Birth Defects (3rd, 2000), corresponding to List 2). From the above knowledge, general toxicity in maternal animals was not described in the animal test, and all the descriptions in humans were from List 2, therefore it was classified in Category 2. |
8 | Specific target organ toxicity - Single exposure | Classification not possible |
- |
- | - | Data are lacking. Besides, it is reported that after administration of 80-grain tablets (about 5.2 g) to a dog, it showed increased pulse rate and behavior indicating loss of vision, no light reflex and dilated pupils were observed, and it died after 12 hours (HSDB (2003)), but it cannot be used for the rationale for classification because the details are unknown. And sodium L-thyroxine (CAS 55-03-8), the sodium salt of the substance, has been used as a medicine, and as adverse effects, there are descriptions of angina and hepatic function disorder as well as circulatory system symptoms such as palpitation, arrhythmia, and increased pulse rate and neurological symptoms such as dizziness, insomnia, tremor, and irritability (Ethical Pharmaceuticals (2010), corresponding to List 1). |
9 | Specific target organ toxicity - Repeated exposure | Classification not possible |
- |
- | - | No data available. Besides, sodium L-thyroxine (CAS 55-03-8), the sodium salt of the substance, has been used as a medicine, and as adverse effects, there are descriptions of angina and hepatic function disorder as well as circulatory system symptoms such as palpitation, arrhythmia, and increased pulse rate and neurological symptoms such as dizziness, insomnia, tremor, and irritability (Ethical Pharmaceuticals (2010)). |
10 | Aspiration hazard | Classification not possible |
- |
- | - | No data available. |
Hazard class | Classification |
Pictogram Signal word |
Hazard statement (code) |
Precautionary statement (code) |
Rationale for the classification | |
---|---|---|---|---|---|---|
11 | Hazardous to the aquatic environment (Acute) | Classification not possible |
- |
- | - | No data available. |
11 | Hazardous to the aquatic environment (Long-term) | Classification not possible |
- |
- | - | The classification is not possible because appropriate data are not obtained. |
12 | Hazardous to the ozone layer | Classification not possible |
- |
- | - | This substance is not listed in the Annexes to the Montreal Protocol. |
|